Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Vaginal versus robotic-assisted abdominal mesh repair for apical prolapse

Official title: A Comparative Analysis of Vaginal Mesh Surgery Versus Robotic-assisted Abdominal Mesh Surgery in the Treatment of Apical Genital Prolapse: a Prospective Randomized Non-inferiority Study.

Run by University of Sao Paulo General Hospital · NCT07359755 · Data updated 2026-11-12

This study will test whether vaginal mesh repair works as well and is as safe as robotic-assisted abdominal mesh repair for women with stage II or higher apical pelvic organ prolapse.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment86 (estimated)
SponsorUniversity of Sao Paulo General Hospital
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedOctober 2027
Study endsJune 2030
Registry record updatedJanuary 22, 2026
Trial IDNCT07359755 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women with apical compartment pelvic organ prolapse stage II or higher who are candidates for elective operative correction and can complete Portuguese-language outcome questionnaires are ideal candidates.

Probably not a fit

Patients who need concomitant procedures that alter pelvic anatomy, have prior pelvic radiotherapy, congenital or acquired urogenital/gastrointestinal anomalies, or other contraindications to elective surgery are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized non-inferiority trial comparing objective outcomes after vaginal mesh repair versus robot-assisted abdominal mesh repair for apical compartment pelvic organ prolapse. Eligible women with stage II or higher apical prolapse are randomized via REDCap to receive either Splentis® vaginal mesh with bilateral sacrospinous anchoring or Upsylon® mesh via robot-assisted colpocervicopexy to the sacral promontory. Primary outcome is objective cure (stage 0 or I) and secondary outcomes include mesh erosion, pain, and symptom-specific quality of life measured with a Portuguese-validated instrument. The sample size is calculated to test non-inferiority based on assumed cure rates for the two approaches.

Why it matters

Potential benefit: If successful, vaginal mesh repair could provide a similarly effective and safe alternative to robotic abdominal repair, potentially offering a less invasive option with shorter recovery and lower resource use.

How similar studies have gone: Robotic sacrocolpopexy has demonstrated high success rates in prior studies while outcomes and safety of transvaginal mesh have been more mixed, so randomized direct comparisons like this are relatively uncommon.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The study will include patients diagnosed with apical compartment genital prolapse of stage II or higher, who have an indication for surgical correction.

Exclusion Criteria:

* The following exclusion criteria will apply: patients who are unable or unwilling to complete validated outcome assessment instruments; those requiring concomitant surgical procedures (e.g., hysterectomy or any other intervention that may alter pelvic floor anatomy);
* individuals with a prior history of pelvic radiotherapy;
* patients with congenital or acquired anomalies of the urogenital or gastrointestinal systems;
* and those with medical conditions that constitute a contraindication to elective surgical intervention.

Where it's running

  • Hospital das Clinicas da Faculdade de Medicina de Sao Paulo
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.